What are anti MRSA antibiotics?
Currently, there are seven common antibiotics used against MRSA, which are: vancomycin, daptomycin, linezolid, Sulfamethoxazole and trimethoprim (TMP-SMZ), quinupristin-dalfopristin, clindamycin and tigecycline.
Where did MRSA come from?
The first documented MRSA outbreak in the United States occurred at a Boston hospital in 1968. For the next two decades most MRSA infections occurred in persons who had contact with hospitals or other health care settings (health care-associated MRSA).
What IV antibiotics treat MRSA?
A number of IV antibiotics can effectively treat MRSA infections, including the following:
- First-line therapy: vancomycin.
- Second-line therapy: daptomycin (Cubicin).
- Third-line therapy: linezolid (Zyvox).
- Fourth-line therapy: tigecycline (Tygacil).
- Fifth-line therapy: quinupristin/dalfopristin (Synercid).
What are risk factors for MRSA?
The commonly associated risk factors for MRSA infection are prolonged hospitalization, intensive care admission, recent hospitalization, recent antibiotic use, MRSA colonization, invasive procedures, HIV infection, admission to nursing homes, open wounds, hemodialysis, and discharge with long-term central venous access …
Does teicoplanin cover UTI?
Serious infections caused by Gram-positive bacteria (e.g. complicated skin and soft-tissue infections, pneumonia, complicated urinary tract infections) Initially 6 mg/kg every 12 hours for 3 doses, then 6 mg/kg once daily.
Why is sulfamethoxazole not used in humans?
Sulfonamides are selective against bacteria because they interfere with the synthesis of folate, a process which does not occur in humans. Humans do not synthesize folate, and must acquire it through diet. Sulfamethoxazole is well-absorbed when administered topically.
How does sulfamethoxazole prevent folic acid synthesis?
It prevents folic acid synthesis in the bacteria that must synthesize their own folic acid. Mammalian cells, and some bacteria, do not synthesize but require preformed folic acid (vitamin B9); they are therefore insensitive to sulfamethoxazole. It was introduced to the United States in 1961.
Does sulfamethoxazole cause hyperkalemia?
The trimethoprim component of sulfamethoxazole and trimethoprim may cause hyperkalemia when administered to patients with underlying disorders of potassium metabolism, with renal insufficiency or when given concomitantly with drugs known to induce hyperkalemia, such as angiotensin converting enzyme inhibitors.
Do sulfamethoxazole and trimethoprim prolong prothrombin time in patients on warfarin?
It has been reported that sulfamethoxazole and trimethoprim may prolong the prothrombin time in patients who are receiving the anticoagulant warfarin (a CYP2C9 substrate).